South Dakota Investment Council boosted its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 186.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,800 shares of the medical technology company’s stock after buying an additional 15,500 shares during the quarter. South Dakota Investment Council’s holdings in Hill-Rom were worth $2,490,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of HRC. Litman Gregory Asset Management LLC bought a new position in shares of Hill-Rom during the second quarter valued at $26,000. Hanseatic Management Services Inc. bought a new stake in shares of Hill-Rom in the first quarter worth $30,000. Tortoise Investment Management LLC acquired a new stake in Hill-Rom in the second quarter valued at $31,000. TRUE Private Wealth Advisors acquired a new stake in Hill-Rom in the second quarter valued at $38,000. Finally, Bay Harbor Wealth Management LLC increased its holdings in Hill-Rom by 78.9% in the second quarter. Bay Harbor Wealth Management LLC now owns 535 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 236 shares during the period. Institutional investors and hedge funds own 82.74% of the company’s stock.

Several brokerages have commented on HRC. ValuEngine downgraded Hill-Rom from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Barclays increased their price target on Hill-Rom from $108.00 to $116.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 6th. KeyCorp raised their price objective on Hill-Rom from $114.00 to $125.00 and gave the stock an “overweight” rating in a research report on Monday, August 5th. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $103.00 price objective on the stock in a research note on Thursday, June 6th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $125.00 target price on shares of Hill-Rom in a report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Hill-Rom currently has an average rating of “Buy” and an average price target of $112.43.

In other Hill-Rom news, SVP Deborah Rasin sold 5,500 shares of Hill-Rom stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $103.00, for a total value of $566,500.00. Following the completion of the sale, the senior vice president now directly owns 20,939 shares in the company, valued at $2,156,717. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Paul Sherwood Johnson sold 6,470 shares of Hill-Rom stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $104.26, for a total value of $674,562.20. Following the completion of the sale, the senior vice president now owns 8,215 shares of the company’s stock, valued at $856,495.90. The disclosure for this sale can be found here. 0.73% of the stock is owned by insiders.

Shares of HRC traded up $0.68 during trading hours on Wednesday, hitting $106.82. 5,955 shares of the stock were exchanged, compared to its average volume of 342,570. Hill-Rom Holdings, Inc. has a fifty-two week low of $81.82 and a fifty-two week high of $109.18. The business has a 50-day moving average of $105.85 and a 200-day moving average of $103.44. The firm has a market capitalization of $7.05 billion, a P/E ratio of 22.47, a price-to-earnings-growth ratio of 2.09 and a beta of 0.87. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.51 and a quick ratio of 1.14.

Hill-Rom (NYSE:HRC) last released its earnings results on Friday, August 2nd. The medical technology company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.02. Hill-Rom had a net margin of 7.45% and a return on equity of 21.26%. The business had revenue of $726.80 million for the quarter, compared to analyst estimates of $718.08 million. During the same quarter in the previous year, the business earned $1.15 earnings per share. Hill-Rom’s revenue for the quarter was up 2.6% on a year-over-year basis. As a group, analysts forecast that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Friday, September 20th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date is Thursday, September 19th. Hill-Rom’s dividend payout ratio is 17.68%.

Hill-Rom Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: What is a short straddle?

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.